System for evaluating quality systems in biotechnology during mergers and acquisitions

Abstract

A system for qualifying biotech quality systems in mergers and acquisitions, comprising: a data collection module configured to capture operational records, quality management documents, validation reports, audit records, and regulatory compliance information from one or more biotechnology organizations; a conformity assessment module configured to analyze the collected information based on predefined regulatory standards, quality assurance protocols, and conformity requirements; and a compatibility assessment module configured to evaluate the operational consistency, process harmonization, and interoperability of biotech quality systems associated with the one or more biotechnology organizations.a verification module configured to validate process records, data integrity parameters, audit histories, and traceability information; a risk analysis module configured to identify compliance gaps, operational inconsistencies, validation deficiencies, and integration-related risks; and a reporting module configured to generate qualification reports, compliance summaries, audit documentation, and risk assessment results.